Cargando…

Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer

Introduction. We performed a review of the literature to elucidate the potential prognostic significance of serum vascular endothelial growth factor (sVEGF) levels in ovarian cancer. Methods. Eligible studies in English and Italian were identified in MEDLINE/PubMed from VEGF discovery to October 201...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bandiera, Elisabetta, Franceschini, Roberta, Specchia, Claudia, Bignotti, Eliana, Trevisiol, Chiara, Gion, Massimo, Pecorelli, Sergio, Santin, Alessandro Davide, Ravaggi, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scholarly Research Network 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3390037/ https://www.ncbi.nlm.nih.gov/pubmed/22792477 http://dx.doi.org/10.5402/2012/245756

Ejemplares similares

Identification of Optimal Reference Genes for Gene Expression Normalization in a Wide Cohort of Endometrioid Endometrial Carcinoma Tissues
por: Romani, Chiara, et al.
Publicado: (2014)

Evaluation of a novel human IgG1 anti-claudin3 antibody that specifically recognizes its aberrantly localized antigen in ovarian cancer cells and that is suitable for selective drug delivery
por: Romani, Chiara, et al.
Publicado: (2015)

The HIV-protease inhibitor saquinavir reduces proliferation, invasion and clonogenicity in cervical cancer cell lines
por: Bandiera, Elisabetta, et al.
Publicado: (2016)

Mammaglobin B is an independent prognostic marker in epithelial ovarian cancer and its expression is associated with reduced risk of disease recurrence
por: Tassi, Renata A, et al.
Publicado: (2009)

Secretoglobin expression in ovarian carcinoma: lipophilin B gene upregulation as an independent marker of better prognosis
por: Bignotti, Eliana, et al.
Publicado: (2013)

Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma
por: Bignotti, Eliana, et al.
Publicado: (2012)

FOXM1 expression is significantly associated with chemotherapy resistance and adverse prognosis in non-serous epithelial ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2017)

Identification of stably expressed reference small non‐coding RNAs for microRNA quantification in high‐grade serous ovarian carcinoma tissues
por: Bignotti, Eliana, et al.
Publicado: (2016)

MAL gene overexpression as a marker of high-grade serous ovarian carcinoma stem-like cells that predicts chemoresistance and poor prognosis
por: Zanotti, Laura, et al.
Publicado: (2017)

Trefoil factor 3: a novel serum marker identified by gene expression profiling in high-grade endometrial carcinomas
por: Bignotti, E, et al.
Publicado: (2008)

The Claudin-Low Subtype of High-Grade Serous Ovarian Carcinoma Exhibits Stem Cell Features
por: Romani, Chiara, et al.
Publicado: (2021)

Low Expression of Claudin-7 as Potential Predictor of Distant Metastases in High-Grade Serous Ovarian Carcinoma Patients
por: Romani, Chiara, et al.
Publicado: (2020)

Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy
por: Bellone, S, et al.
Publicado: (2013)

Pre-treatment Serum HE4 Level as a Novel Independent Prognostic Biomarker for Uterine Cervical Carcinoma Patients
por: Bignotti, Eliana, et al.
Publicado: (2020)

Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
por: Bignotti, E, et al.
Publicado: (2011)

FXYD5 (Dysadherin) upregulation predicts shorter survival and reveals platinum resistance in high-grade serous ovarian cancer patients
por: Tassi, Renata A., et al.
Publicado: (2019)

Insufficient uptake of systematic search methods in oncological clinical practice guideline: a systematic review
por: Trevisiol, Chiara, et al.
Publicado: (2019)

Comprehensive Profiling of Hypoxia-Related miRNAs Identifies miR-23a-3p Overexpression as a Marker of Platinum Resistance and Poor Prognosis in High-Grade Serous Ovarian Cancer
por: Todeschini, Paola, et al.
Publicado: (2021)

Transcriptional Characterization of Stage I Epithelial Ovarian Cancer: A Multicentric Study
por: Calura, Enrica, et al.
Publicado: (2019)

Genome-wide study of salivary miRNAs identifies miR-423-5p as promising diagnostic and prognostic biomarker in oral squamous cell carcinoma
por: Romani, Chiara, et al.
Publicado: (2021)

Induction of tumour-specific CD8(+) cytotoxic T lymphocytes by tumour lysate-pulsed autologous dendritic cells in patients with uterine serous papillary cancer
por: Santin, A D, et al.
Publicado: (2002)

Serum Tumor Markers in Paraneoplastic Neurologic Syndromes: A Systematic Review of Guidelines
por: Trevisiol, Chiara, et al.
Publicado: (2021)

Claudin3 is localized outside the tight junctions in human carcinomas
por: Corsini, Michela, et al.
Publicado: (2018)

A KRAS-variant is a Biomarker of Poor Outcome, Platinum Chemotherapy Resistance and a Potential Target for Therapy in Ovarian Cancer
por: Ratner, Elena S., et al.
Publicado: (2011)

L1CAM expression as a predictor of platinum response in high‐risk endometrial carcinoma
por: Romani, Chiara, et al.
Publicado: (2022)

Use of Routine Health Datasets to Assess the Appropriateness of Diagnostic Tests in the Follow-Up of Breast Cancer Patients: A Population-Based Study on 3930 Patients
por: Gion, Massimo, et al.
Publicado: (2022)

Functional profiles of curatively treated adenoid cystic carcinoma unveil prognostic features and potentially targetable pathways
por: Romani, Chiara, et al.
Publicado: (2023)

Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma
por: Shen, G H, et al.
Publicado: (2000)

Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer
por: Masoumi Moghaddam, Samar, et al.
Publicado: (2011)

Infiltration by CXCL10 Secreting Macrophages Is Associated With Antitumor Immunity and Response to Therapy in Ovarian Cancer Subtypes
por: Ardighieri, Laura, et al.
Publicado: (2021)

Integrated Biomarker Analysis Reveals L1CAM as a Potential Stratification Marker for No Specific Molecular Profile High-Risk Endometrial Carcinoma
por: Ravaggi, Antonella, et al.
Publicado: (2022)

RERT: A Novel Regression Tree Approach to Predict Extrauterine Disease in Endometrial Carcinoma Patients
por: Vezzoli, Marika, et al.
Publicado: (2017)

VEGF-D Serum Level as a Potential Predictor of Lymph Node Metastasis and Prognosis in Vulvar Squamous Cell Carcinoma Patients
por: Ravaggi, Antonella, et al.
Publicado: (2022)

Kinase-driven metabolic signalling as a predictor of response to carboplatin–paclitaxel adjuvant treatment in advanced ovarian cancers
por: Sereni, Maria Isabella, et al.
Publicado: (2017)

Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trial
por: Gurizzan, Cristina, et al.
Publicado: (2021)

Vascular endothelial growth factor as an angiogenic swich in ovarian carcinoma
por: Bajpai, Jyoti
Publicado: (2013)

Expression of Vascular Endothelial Growth Factor (VEGF) and Epidermal Growth Factor Receptor (EGFR) in Patients With Serous Ovarian Carcinoma and Their Clinical Significance
por: Ranjbar, Reza, et al.
Publicado: (2015)

Gene Expression Profiling of Olfactory Neuroblastoma Helps Identify Prognostic Pathways and Define Potentially Therapeutic Targets
por: Romani, Chiara, et al.
Publicado: (2021)

The effects of ovarian cancer cell-derived exosomes on vascular endothelial growth factor expression in endothelial cells
por: Ghorbanian, Mohammad, et al.
Publicado: (2019)

Clinical Significance of Serum Vascular Endothelial-Cadherin Levels in Inflammatory Skin Diseases
por: Kuriyama, Haruka, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pnsocoonj0qvs1hactm4p8lkhr